|
Name |
(+)-Oxypenicinoline B
|
Molecular Formula | C16H16N2O3 | |
IUPAC Name* |
11-methoxy-9-methyl-9,15-diazatetracyclo[8.6.0.03,8.011,15]hexadeca-1(10),3,5,7-tetraene-2,16-dione
|
|
SMILES |
COC12CCCN1C(=O)c1c2n(C)c2ccccc2c1=O
|
|
InChI |
InChI=1S/C16H16N2O3/c1-17-11-7-4-3-6-10(11)13(19)12-14(17)16(21-2)8-5-9-18(16)15(12)20/h3-4,6-7H,5,8-9H2,1-2H3/t16-/m1/s1
|
|
InChIKey |
FRGYPSSMWFKGNO-MRXNPFEDSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 284.32 | ALogp: | 1.6 |
HBD: | 0 | HBA: | 4 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 51.5 | Aromatic Rings: | 4 |
Heavy Atoms: | 21 | QED Weighted: | 0.806 |
Caco-2 Permeability: | -4.62 | MDCK Permeability: | 0.00002400 |
Pgp-inhibitor: | 0.008 | Pgp-substrate: | 0.006 |
Human Intestinal Absorption (HIA): | 0.012 | 20% Bioavailability (F20%): | 0.019 |
30% Bioavailability (F30%): | 0.025 |
Blood-Brain-Barrier Penetration (BBB): | 0.904 | Plasma Protein Binding (PPB): | 66.07% |
Volume Distribution (VD): | 1.284 | Fu: | 33.52% |
CYP1A2-inhibitor: | 0.77 | CYP1A2-substrate: | 0.934 |
CYP2C19-inhibitor: | 0.504 | CYP2C19-substrate: | 0.923 |
CYP2C9-inhibitor: | 0.503 | CYP2C9-substrate: | 0.732 |
CYP2D6-inhibitor: | 0.036 | CYP2D6-substrate: | 0.419 |
CYP3A4-inhibitor: | 0.319 | CYP3A4-substrate: | 0.882 |
Clearance (CL): | 2.288 | Half-life (T1/2): | 0.192 |
hERG Blockers: | 0.01 | Human Hepatotoxicity (H-HT): | 0.284 |
Drug-inuced Liver Injury (DILI): | 0.575 | AMES Toxicity: | 0.22 |
Rat Oral Acute Toxicity: | 0.735 | Maximum Recommended Daily Dose: | 0.352 |
Skin Sensitization: | 0.341 | Carcinogencity: | 0.97 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.041 |
Respiratory Toxicity: | 0.35 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004691 | 1.000 | D06GKN | 0.386 | ||||
ENC004693 | 0.742 | D0K7WK | 0.356 | ||||
ENC004686 | 0.742 | D08UGJ | 0.330 | ||||
ENC004687 | 0.657 | D06BCB | 0.327 | ||||
ENC004692 | 0.657 | D08EOD | 0.299 | ||||
ENC004689 | 0.507 | D04ACW | 0.290 | ||||
ENC004690 | 0.507 | D0K0VO | 0.290 | ||||
ENC002715 | 0.457 | D0RA9E | 0.277 | ||||
ENC002158 | 0.452 | D0J5KF | 0.276 | ||||
ENC004684 | 0.427 | D0U7GK | 0.273 |